Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone.

Pigment epithelium-derived factor (PEDF) has proven anti-osteosarcoma activity. However, the mechanism(s) underpinning its ability to reduce primary bone tumour (osteosarcoma) metastasis is unknown.
Adult and fetal murine bone were immunostained for PEDF, collagen I (major protein in bone) and its processing proteins, heat shock protein 47 (HSP47, a chaperone protein for collagen I), membrane type I matrix metalloproteinase (MT1-MMP, a collagenase), and matrix metalloproteinase 2 (MMP-2, which is activated by MT1-MMP). Immunoblotting and immunocytochemistry were used to observe levels of the above biomarkers when human osteosarcoma cells were treated with PEDF.
Immunohistochemical staining in adult and fetal bone mirrors collagen I. PEDF localised to ridges of trabecular bone in tibial cortex and to megakaryocytes within bone marrow. Second, we observed that PEDF upregulates collagen I, HSP47 and MT1-MMP, while downregulating MMP-2 in osteosarcoma cells in vitro.
PEDF is a promising antagonist to osteosarcoma cell metastasis via downregulation of MMP-2, and can induce tumour cells to further adopt differentiative properties, thereby possibly reducing their aggressive growth in vitro and in vivo.
AuthorsMarice B Alcantara, Natalie Nemazannikova, Mina Elahy, Crispin R Dass
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 66 Issue 11 Pg. 1586-92 (Nov 2014) ISSN: 2042-7158 [Electronic] England
PMID25175851 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 Royal Pharmaceutical Society.
Chemical References
  • Antineoplastic Agents
  • Biomarkers
  • Collagen Type I
  • Eye Proteins
  • HSP47 Heat-Shock Proteins
  • Nerve Growth Factors
  • Serpins
  • pigment epithelium-derived factor
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 1
  • Animals
  • Antineoplastic Agents (metabolism, pharmacology, therapeutic use)
  • Biomarkers (metabolism)
  • Bone Marrow (metabolism)
  • Bone Neoplasms (drug therapy, metabolism)
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Collagen Type I (metabolism)
  • Down-Regulation
  • Eye Proteins (metabolism, pharmacology, therapeutic use)
  • Fetus
  • HSP47 Heat-Shock Proteins (metabolism)
  • Humans
  • Matrix Metalloproteinase 1 (metabolism)
  • Matrix Metalloproteinase 2 (metabolism)
  • Mice, Inbred BALB C
  • Nerve Growth Factors (metabolism, pharmacology, therapeutic use)
  • Osteosarcoma (drug therapy, metabolism)
  • Serpins (metabolism, pharmacology, therapeutic use)
  • Tibia (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: